|
Roldán V, Marín F. The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists. Thromb Haemost. 2015 Apr;113(4):671-3. doi: 10.1160/TH14-12-1087. PubMed PMID: 25673326.
AÑO: 2015; IF: 5.255
|
25673326
|
Mont L, Marín F, Dalmau FG, Martínez MS, Cullere JG. Clinical development of rivaroxaban: emerging new clinical evidences? Future Cardiol. 2015 Sep;11(5):565-83. doi: 10.2217/fca.15.31. Review. PubMed PMID: 26111102.
AÑO: 2015
|
|
Parrilla G., Carreón E., Zamarro J., Espinosa de Rueda M., García-Villalba B., Marín F., Hernández-Fernández F., Morales A., Fernández-Vivas M., Núñez R., Moreno A. Recanalization and Mortality Rates of Thrombectomy With Stent-Retrievers in Octogenarian Patients with Acute Ischemic Stroke. CardioVascular and Interventional Radiology. April 2015. 38:288-294. 10.1007/s00270-014-0920-3
AÑO: 2015; IF: 2.144
|
|
Marín F, Roldán V. Biomarkers: GDF-15 and risk stratification in atrial fibrillation. Nat Rev Cardiol. 2015 Jan;12(1):8-9. doi: 10.1038/nrcardio.2014.190. Review. PubMed PMID: 25421166.
AÑO: 2015; IF: 49.421
|
|
Vílchez JA, Pérez-Cuellar M, Marín F, Gallego P, Manzano-Fernández S, Valdés M, Vicente V, Noguera-Velasco JA, Lip GY, Ordóñez-Llanos J, Roldán V. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation. Eur J Clin Invest. 2015 Sep;45(9):899-905. doi: 10.1111/eci.12482. PubMed PMID: 26081996.
AÑO: 2015; IF: 2.687
|